This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Academy of Military Medical Sciences, Sichuan University, Chengdu Aupone Pharmaceutical Co., Ltd. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 14 
2 out of 263 
1 out of 1 Years Active: 2026
Title: Fei Xue: Innovator in C-Nucleoside Synthesis
Introduction
Fei Xue is a prominent inventor based in Chengdu, China. He has made significant contributions to the field of chemistry, particularly in the synthesis of C-nucleoside compounds. His innovative methods have implications for large-scale pharmaceutical production.
Latest Patents
Fei Xue holds a patent for a method for synthesizing a C-nucleoside compound. This method, represented by Formula (III) or its salt, boasts a high reaction yield and is simple to operate. It utilizes a single metal reagent and maintains stable reaction temperature conditions. The process does not require frequent changes to the reaction system, making it suitable for scale-up synthesis and large-scale production of Remdesivir, all while keeping costs low.
Career Highlights
Throughout his career, Fei Xue has worked with esteemed institutions such as Sichuan University and the Academy of Military Medical Sciences. His work has been instrumental in advancing the field of medicinal chemistry.
Collaborations
Fei Xue has collaborated with notable colleagues, including Yong Qin and Wu Zhong. Their combined expertise has contributed to the success of various research projects.
Conclusion
Fei Xue's innovative approach to synthesizing C-nucleoside compounds highlights his significant role in the field of chemistry. His contributions are paving the way for advancements in pharmaceutical production.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile